Welcome to our dedicated page for B. Riley Financi SEC filings (Ticker: RILYZ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on B. Riley Financi's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into B. Riley Financi's regulatory disclosures and financial reporting.
B. Riley Financial, Inc. reported substantial portfolio and structural activity across 2024-2025, including multiple divestitures, impairments, and new financing arrangements. The company reported an aggregate market value of common stock held by non-affiliates of approximately $337.1 million and 30,597,066 shares outstanding as of September 16, 2025. Material asset sales generated liquidity: bebe brand assets sold for approximately $46.6 million (net cash), Great American NewCo. transaction produced approximately $167.1 million distributable to the company, Atlantic Coast Recycling cash proceeds were $68.6 million, GlassRatner and Farber were sold for aggregate cash consideration of $117.8 million, and Wealth Management assets sold to Stifel for $26.0 million.
The company recorded large non-cash impairments including a $287.0 million markdown related to its Freedom VCM investment, additional impairments aggregating $118.0 million, and a Nogin goodwill impairment of $57,664. Debt actions include a new credit facility with Oaktree ($125.0 million initial term loan and $35.0 million delayed draw) with related warrants to purchase ~1,832,290 shares at $5.14, and issuance of 8.00% Senior Secured Second Lien Notes due 2028 through private exchanges, with related warrants to purchase ~914,000 shares. Nogin’s assets were transferred under a deed of assignment on March 31, 2025 and are no longer controlled by the company.